Axogen, Inc. Share Price & Technical Analysis
AXGN · $41.12 (+0.54%)
Healthcare / Medical Devices
$41.12
+0.54%
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-5% return in May, -11% avg return in past 3 year May month.
28% return in 2026, 62% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 7% | -10% | 7% | 29% | -5% | – | – | – | – | – | – | – | 28% |
| 25 | 9% | 10% | -8% | -11% | -33% | 1% | 21% | 23% | 11% | 25% | 29% | 12% | 89% |
| 24 | 43% | 8% | -24% | -21% | 6% | 4% | 17% | 47% | 8% | 0% | -1% | 18% | 105% |
| 23 | -6% | -13% | 13% | -5% | -6% | 7% | -5% | -27% | -21% | -24% | 74% | 5% | -8% |
| 22 | -8% | 7% | -14% | -10% | 35% | -16% | 13% | 1% | 28% | -6% | -5% | -9% | 15% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Uptrend
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue. In addition, the company offers peripheral nerve tissue recovery and acquisition, and testing, as well as donor medical review and release, debridement and other processing steps, packaging, and sterilization. It provides its products to hospitals, surgery centers and military hospitals, calling on surgeons, including plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and certain oral and maxillofacial surgeons through independent in-country distributors. The company is headquartered in Alachua, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$2.19B
P/E ratio
—
52W high
$45.83
52W low
$9.22
Volume
34,961
Beta
1.17
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Axogen, Inc. share price today?
- Axogen, Inc. (AXGN) last traded around $41.12 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does AXGN have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for AXGN. Download the app for real-time alerts.
- How can I analyze Axogen, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.